002864 盘龙药业
已收盘 05-09 15:00:00
资讯
新帖
简况
盘龙药业:龙头地位不断巩固 秦药配方颗粒、饮片构筑新增长极
长城证券股份有... · 04-29
盘龙药业:龙头地位不断巩固 秦药配方颗粒、饮片构筑新增长极
盘龙药业:公司主导产品盘龙七片市场份额排名第一
证券之星 · 04-28
盘龙药业:公司主导产品盘龙七片市场份额排名第一
图解盘龙药业一季报:第一季度单季净利润同比增0.33%
证券之星 · 04-24
图解盘龙药业一季报:第一季度单季净利润同比增0.33%
陕西盘龙药业集团股份有限公司申请II类会议
金融界 · 04-11
陕西盘龙药业集团股份有限公司申请II类会议
盘龙药业:公司将通过加大研发投入、优化产品结构等方式增强盈利能力
证券之星 · 03-04
盘龙药业:公司将通过加大研发投入、优化产品结构等方式增强盈利能力
盘龙药业(002864.SZ)2024年第三季度权益分派:每10股派0.5元
智通财经 · 02-07
盘龙药业(002864.SZ)2024年第三季度权益分派:每10股派0.5元
盘龙药业:已回购37.35万股 占公司总股本比例0.35%
中国财富通 · 02-06
盘龙药业:已回购37.35万股 占公司总股本比例0.35%
盘龙药业获得发明专利授权:“一种3-四唑基甲基-1,3,5-三嗪-2,4-二酮类化合物及其制备方法和应用”
证券之星 · 01-21
盘龙药业获得发明专利授权:“一种3-四唑基甲基-1,3,5-三嗪-2,4-二酮类化合物及其制备方法和应用”
盘龙药业:公司“秦岭盘龙谷康养文旅-西安医学院附属秦岭康复医院项目”尚在建设过程中
证券之星 · 01-10
盘龙药业:公司“秦岭盘龙谷康养文旅-西安医学院附属秦岭康复医院项目”尚在建设过程中
盘龙药业最新公告:公司获得食品生产许可证
证券之星 · 01-08
盘龙药业最新公告:公司获得食品生产许可证
盘龙药业(002864.SZ)获食品生产许可证
智通财经 · 01-08
盘龙药业(002864.SZ)获食品生产许可证
【A股午评:沪指缩量调整半日跌0.32% 数据电源概念领涨】A股三大指数早盘多数调整,截至午盘,沪指跌0.32%,深成指平收,创业板指跌0.55%,北证50指数跌1.08%。全市场半日成交额6106亿元,较上日缩量894亿元。全市场超3000只个股飘绿。板块题材上,数据电源中心、铜缆高速连接、培育钻石、转基因板块涨幅居前;流感、中药板块跌幅居前。盘面上,数据电源中心概念股持续活跃,华塑科技20cm涨停,中恒电气、华西能源、融发核电涨停。铜缆高速连接板块反弹,鑫科材料、得润电子涨停,太辰光涨超10%。消费电子概念活跃,维信诺、徕木股份、绿联科技涨停,鹏鼎控股、安克创新涨超5%。流感概念股跌幅居前,亨迪药业跌超10%,盘龙药业、神奇制药、特一药业等多股跌超5%。零售方向延续调整,中百集团、东百集团、益民集团跌停。此外,顺钠股份、瑞和股份盘中上演地天板行情。
金融界 · 01-07
【A股午评:沪指缩量调整半日跌0.32% 数据电源概念领涨】A股三大指数早盘多数调整,截至午盘,沪指跌0.32%,深成指平收,创业板指跌0.55%,北证50指数跌1.08%。全市场半日成交额6106亿元,较上日缩量894亿元。全市场超3000只个股飘绿。板块题材上,数据电源中心、铜缆高速连接、培育钻石、转基因板块涨幅居前;流感、中药板块跌幅居前。盘面上,数据电源中心概念股持续活跃,华塑科技20cm涨停,中恒电气、华西能源、融发核电涨停。铜缆高速连接板块反弹,鑫科材料、得润电子涨停,太辰光涨超10%。消费电子概念活跃,维信诺、徕木股份、绿联科技涨停,鹏鼎控股、安克创新涨超5%。流感概念股跌幅居前,亨迪药业跌超10%,盘龙药业、神奇制药、特一药业等多股跌超5%。零售方向延续调整,中百集团、东百集团、益民集团跌停。此外,顺钠股份、瑞和股份盘中上演地天板行情。
【中药板块盘初下挫,大唐药业、盘龙药业跌超7%】中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。
金融界 · 01-07
【中药板块盘初下挫,大唐药业、盘龙药业跌超7%】中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。
【流感概念早盘走低 亨迪药业跌超10%】流感概念早盘走低,亨迪药业跌超10%,一品红、香雪制药、粤万年青、盘龙药业、神奇制药等跟跌。
金融界 · 01-07
【流感概念早盘走低 亨迪药业跌超10%】流感概念早盘走低,亨迪药业跌超10%,一品红、香雪制药、粤万年青、盘龙药业、神奇制药等跟跌。
A股中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。
美港电讯 · 01-07
A股中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。
【A股分红派息转增一览:1股今日股权登记】根据上市公司权益分配方案梳理统计,1只A股今日股权登记。其中,1股拟派息。分红派息方面,1只个股分红派息的股权登记日为1月2日。山东赫达分红力度最大,每10股分别派息1.50元。此外,还有1股抛出分红派息预案,盘龙药业拟分红力度最大,每10股拟派息0.5元。
金融界 · 01-01
【A股分红派息转增一览:1股今日股权登记】根据上市公司权益分配方案梳理统计,1只A股今日股权登记。其中,1股拟派息。分红派息方面,1只个股分红派息的股权登记日为1月2日。山东赫达分红力度最大,每10股分别派息1.50元。此外,还有1股抛出分红派息预案,盘龙药业拟分红力度最大,每10股拟派息0.5元。
【盘龙药业2024年前三季度利润分配方案:拟10派0.5元】 盘龙药业1月1日晚间公告,公司拟定2024年前三季度利润分配方案:拟每10股派发现金红利金额为0.5元,预计合计派发现金529.54万元。
金融界 · 01-01
【盘龙药业2024年前三季度利润分配方案:拟10派0.5元】 盘龙药业1月1日晚间公告,公司拟定2024年前三季度利润分配方案:拟每10股派发现金红利金额为0.5元,预计合计派发现金529.54万元。
国元证券:给予盘龙药业买入评级
证券之星 · 2024-12-18
国元证券:给予盘龙药业买入评级
医药板块又爆了!医药商业“扛大旗”,行业将迎反转曙光?
格隆汇 · 2024-12-12
医药板块又爆了!医药商业“扛大旗”,行业将迎反转曙光?
异动快报:盘龙药业(002864)12月12日10点12分触及涨停板
证券之星 · 2024-12-12
异动快报:盘龙药业(002864)12月12日10点12分触及涨停板
加载更多
公司概况
公司名称:
陕西盘龙药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2017-11-16
主营业务:
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售及医药物流。公司主要产品包括盘龙七片、白芍总苷胶囊、痹祺胶囊、尪痹胶囊、尪痹片、盘龙七药酒、骨松宝片、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、益母草颗粒、参苓白术散、小儿麦枣咀嚼片、小儿咽扁颗粒、公司大健康产品。公司被评为“国家企业技术中心”。2020年6月6日公司的独家品种盘龙七片被评选为首届陕西“秦药”优势中成药品种,盘龙七片处方中的盘龙七药材被评为陕西“秦药”区域特色中草药,进一步提升了公司盘龙品牌。
发行价格:
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":27.5,"timestamp":1746774213000,"preClose":27.5,"halted":0,"volume":2830851,"delay":0,"changeRate":0,"floatShares":73984600,"shares":106000000,"eps":1.1326,"marketStatus":"已收盘","change":0,"latestTime":"05-09 15:00:00","open":27.5,"high":27.98,"low":27.33,"amount":78305000,"amplitude":0.0236,"askPrice":27.51,"askSize":31,"bidPrice":27.5,"bidSize":45,"shortable":0,"etf":0,"ttmEps":1.1326,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":27.5,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":30.25,"lowLimit":24.75,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":106280960,"isCdr":false,"pbRate":1.76,"roa":"--","peRate":24.280417,"roe":"1.89%","epsLYR":1.15,"committee":0.068285,"marketValue":2923000000,"turnoverRate":0.0383,"status":2,"floatMarketCap":2035000000},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2531228618","title":"盘龙药业:龙头地位不断巩固 秦药配方颗粒、饮片构筑新增长极","url":"https://stock-news.laohu8.com/highlight/detail?id=2531228618","media":"长城证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531228618?lang=zh_cn&edition=full","pubTime":"2025-04-29 13:35","pubTimestamp":1745904958,"startTime":"0","endTime":"0","summary":"2025 年Q1,公司实现营收、归母净利润分别为2.50 亿元、0.31 亿元,分别同比增长19.08%、0.33%,主要系本期中药饮片销售规模增长,销量增加所致。主导产品盘龙七片市占率不断提升,竞争优势明显。区位优势得天独厚,中药配方颗粒、中药饮片业构筑新增长极。2024 年,公司中药饮片业务实现营收0.91 亿元,同比增长292.84%。根据公司2025 年一季报,截至2025 年Q1,公司账上货币资金达11.66 亿元,较为充沛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042913360797499a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042913360797499a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["562390","561510","002864","BK0239"],"gpt_icon":0},{"id":"2530348413","title":"盘龙药业:公司主导产品盘龙七片市场份额排名第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2530348413","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530348413?lang=zh_cn&edition=full","pubTime":"2025-04-28 11:33","pubTimestamp":1745811200,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业(002864)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,贵公司生产的药品中,有在细分领域中占据市场份额较大的吗?谢谢!盘龙药业回复:尊敬的投资者您好!据米内网发布资料显示,2024年H1在我国城市及县级公立医院骨骼肌肉系统风湿性疾病领域中成药市场中,公司主导产品盘龙七片市场份额排名第一,市场份额为8.05%。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042800012778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2530580962","title":"图解盘龙药业一季报:第一季度单季净利润同比增0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530580962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530580962?lang=zh_cn&edition=full","pubTime":"2025-04-25 03:32","pubTimestamp":1745523142,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业2025年一季报显示,公司主营收入2.5亿元,同比上升19.08%;归母净利润3124.93万元,同比上升0.33%;扣非净利润2875.29万元,同比上升18.6%;负债率28.18%,投资收益-5.31万元,财务费用-665.54万元,毛利率53.91%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500001760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"gpt_icon":0},{"id":"2526864439","title":"陕西盘龙药业集团股份有限公司申请II类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2526864439","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526864439?lang=zh_cn&edition=full","pubTime":"2025-04-12 05:06","pubTimestamp":1744405562,"startTime":"0","endTime":"0","summary":"陕西盘龙药业集团股份有限公司,成立于1997年,位于商洛市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,陕西盘龙药业集团股份有限公司共对外投资了6家企业,参与招投标项目1653次,知识产权方面有商标信息161条,专利信息92条,此外企业还拥有行政许可59个。主要股东信息显示,陕西盘龙药业集团股份有限公司由谢晓林持股34.9743%、张水平持股1.4198%、张志红持股1.4114%、谢晓锋持股0.9221%、吴杰持股0.8468%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/12050649506402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2516675734","title":"盘龙药业:公司将通过加大研发投入、优化产品结构等方式增强盈利能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516675734?lang=zh_cn&edition=full","pubTime":"2025-03-04 21:00","pubTimestamp":1741093216,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业03月04日在投资者关系平台上答复投资者关心的问题。此外,公司还将通过品牌建设和市场推广,提升公司知名度,吸引更多投资者的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400039032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2509132107","title":"盘龙药业(002864.SZ)2024年第三季度权益分派:每10股派0.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509132107","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509132107?lang=zh_cn&edition=full","pubTime":"2025-02-07 18:26","pubTimestamp":1738923961,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盘龙药业(002864.SZ)发布公告,公司2024年第三季度权益分派方案为:以公司现有总股本剔除已回购股份后为基数,向全体股东每10股派0.500001元人民币现金(含税),本次权益分派股权登记日为:2025年2月14日,除权除息日为:2025年2月17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"盘龙药业(002864.SZ)2024年第三季度权益分派:每10股派0.5元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2509225704","title":"盘龙药业:已回购37.35万股 占公司总股本比例0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509225704","media":"中国财富通","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509225704?lang=zh_cn&edition=full","pubTime":"2025-02-06 18:30","pubTimestamp":1738837824,"startTime":"0","endTime":"0","summary":"中国财富通2月6日 - 盘龙药业(002864)公告称,截至1月31日,公司通过回购专用证券账户使用自有资金以集中竞价方式累计回购公司股份数量为373,500股,占公司总股本的0.35%。最高价格为28.50元/股,最低价格为25.71元/股,合计支付的总金额为人民币10,002,880.25元(不含交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=YJ1g2c3oBlM%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2505003192","title":"盘龙药业获得发明专利授权:“一种3-四唑基甲基-1,3,5-三嗪-2,4-二酮类化合物及其制备方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2505003192","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505003192?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:27","pubTimestamp":1737484044,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示盘龙药业新获得一项发明专利授权,专利名为“一种3-四唑基甲基-1,3,5-三嗪-2,4-二酮类化合物及其制备方法和应用”,专利申请号为CN202210916662.8,授权日为2025年1月21日。今年以来盘龙药业新获得专利授权1个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200002699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2502779600","title":"盘龙药业:公司“秦岭盘龙谷康养文旅-西安医学院附属秦岭康复医院项目”尚在建设过程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2502779600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502779600?lang=zh_cn&edition=full","pubTime":"2025-01-10 09:00","pubTimestamp":1736470855,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业01月09日在投资者关系平台上答复投资者关心的问题。公司“秦岭盘龙谷康养文旅-西安医学院附属秦岭康复医院项目”尚在建设过程中,后期进展请关注公司公告。用于流行性感冒,发冷发烧,四肢酸懒,头痛咳嗽,咽喉肿痛。用于热毒壅盛所致的发热面赤、烦躁口渴、咽喉肿痛;流感、上呼吸道感染见上述证候者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011000007314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2501741309","title":"盘龙药业最新公告:公司获得食品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2501741309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501741309?lang=zh_cn&edition=full","pubTime":"2025-01-08 18:19","pubTimestamp":1736331593,"startTime":"0","endTime":"0","summary":"盘龙药业公告,公司近日收到商洛市行政审批服务局颁发的《食品生产许可证》,具备了食品固体饮料的生产资质,有助于公司开展相关生产经营活动。上述事项符合公司“一体两翼”发展战略,预计短期内不会对公司的经营及财务状况产生重大影响。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010800032550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2501469749","title":"盘龙药业(002864.SZ)获食品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2501469749","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501469749?lang=zh_cn&edition=full","pubTime":"2025-01-08 18:12","pubTimestamp":1736331157,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盘龙药业(002864.SZ)公告,公司收到商洛市行政审批服务局颁发的《食品生产许可证》,食品类别为:饮料。本次取得《食品生产许可证》,使公司具备了食品固体饮料的生产资质,有助于公司开展相关生产经营活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1235008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2501104102","title":"【A股午评:沪指缩量调整半日跌0.32% 数据电源概念领涨】A股三大指数早盘多数调整,截至午盘,沪指跌0.32%,深成指平收,创业板指跌0.55%,北证50指数跌1.08%。全市场半日成交额6106亿元,较上日缩量894亿元。全市场超3000只个股飘绿。板块题材上,数据电源中心、铜缆高速连接、培育钻石、转基因板块涨幅居前;流感、中药板块跌幅居前。盘面上,数据电源中心概念股持续活跃,华塑科技20cm涨停,中恒电气、华西能源、融发核电涨停。铜缆高速连接板块反弹,鑫科材料、得润电子涨停,太辰光涨超10%。消费电子概念活跃,维信诺、徕木股份、绿联科技涨停,鹏鼎控股、安克创新涨超5%。流感概念股跌幅居前,亨迪药业跌超10%,盘龙药业、神奇制药、特一药业等多股跌超5%。零售方向延续调整,中百集团、东百集团、益民集团跌停。此外,顺钠股份、瑞和股份盘中上演地天板行情。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501104102","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501104102?lang=zh_cn&edition=full","pubTime":"2025-01-07 11:31","pubTimestamp":1736220715,"startTime":"0","endTime":"0","summary":"全市场半日成交额6106亿元,较上日缩量894亿元。盘面上,数据电源中心概念股持续活跃,华塑科技20cm涨停,中恒电气、华西能源、融发核电涨停。铜缆高速连接板块反弹,鑫科材料、得润电子涨停,太辰光涨超10%。流感概念股跌幅居前,亨迪药业跌超10%,盘龙药业、神奇制药、特一药业等多股跌超5%。零售方向延续调整,中百集团、东百集团、益民集团跌停。此外,顺钠股份、瑞和股份盘中上演地天板行情。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07113147193673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000533","002364","600824","BK0214","BK0257","159732","002728","159982","399006","BK0078","BK0224","BK0209","BK0201","002055","300866","600613","BK0035","BK0123","BK0131","BK0102","BK0233","BK0259","BK0158","600255","BK0184","301211","399001","002938","600693","BK0098","399300","BK0156","BK0152","BK0251","603633","000759","002387","BK0138","301606","BK0239","BK0020","BK0185","002864","002630","301157","300570","002366","002620","BK0196","BK0065"],"gpt_icon":0},{"id":"2501215153","title":"【中药板块盘初下挫,大唐药业、盘龙药业跌超7%】中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501215153","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501215153?lang=zh_cn&edition=full","pubTime":"2025-01-07 09:35","pubTimestamp":1736213705,"startTime":"0","endTime":"0","summary":"中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07093547190119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","002275","605199","BK0070","BK0239","BK0004","BK0146","301111","BK0096","300147","BK0114","BK0060","BK0056","002864","BK0028","002390"],"gpt_icon":0},{"id":"2501179215","title":"【流感概念早盘走低 亨迪药业跌超10%】流感概念早盘走低,亨迪药业跌超10%,一品红、香雪制药、粤万年青、盘龙药业、神奇制药等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501179215","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501179215?lang=zh_cn&edition=full","pubTime":"2025-01-07 09:34","pubTimestamp":1736213684,"startTime":"0","endTime":"0","summary":"流感概念早盘走低,亨迪药业跌超10%,一品红、香雪制药、粤万年青、盘龙药业、神奇制药等跟跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07093447190114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300723","600613","BK0239","BK0070","BK0020","BK0028","BK0077","300147","002864","301111","BK0060","301211"],"gpt_icon":0},{"id":"2501153872","title":"A股中药板块盘初下挫,大唐药业、盘龙药业跌超7%,香雪制药跌超6%,葫芦娃跌超4%,粤万年青、信邦制药、桂林三金跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501153872","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501153872?lang=zh_cn&edition=full","pubTime":"2025-01-07 09:33","pubTimestamp":1736213639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","399300","BK0188","BK0146","BK0096","002275","300147","002864","BK0056","002390","BK0028","BK0239","BK0070","BK0114","605199","BK0004","301111","BK0060"],"gpt_icon":0},{"id":"2500865957","title":"【A股分红派息转增一览:1股今日股权登记】根据上市公司权益分配方案梳理统计,1只A股今日股权登记。其中,1股拟派息。分红派息方面,1只个股分红派息的股权登记日为1月2日。山东赫达分红力度最大,每10股分别派息1.50元。此外,还有1股抛出分红派息预案,盘龙药业拟分红力度最大,每10股拟派息0.5元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500865957","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500865957?lang=zh_cn&edition=full","pubTime":"2025-01-02 07:48","pubTimestamp":1735775305,"startTime":"0","endTime":"0","summary":"根据上市公司权益分配方案梳理统计,1只A股今日股权登记。其中,1股拟派息。分红派息方面,1只个股分红派息的股权登记日为1月2日。山东赫达分红力度最大,每10股分别派息1.50元。此外,还有1股抛出分红派息预案,盘龙药业拟分红力度最大,每10股拟派息0.5元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/02074847022958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["399300","BK0229","159982","002864","002810","BK0239"],"gpt_icon":0},{"id":"2500600756","title":"【盘龙药业2024年前三季度利润分配方案:拟10派0.5元】 盘龙药业1月1日晚间公告,公司拟定2024年前三季度利润分配方案:拟每10股派发现金红利金额为0.5元,预计合计派发现金529.54万元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500600756","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500600756?lang=zh_cn&edition=full","pubTime":"2025-01-01 18:13","pubTimestamp":1735726439,"startTime":"0","endTime":"0","summary":"盘龙药业1月1日晚间公告,公司拟定2024年前三季度利润分配方案:拟每10股派发现金红利金额为0.5元,预计合计派发现金529.54万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/01181347020983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2492797046","title":"国元证券:给予盘龙药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492797046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492797046?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:42","pubTimestamp":1734514940,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛近期对盘龙药业进行研究并发布了研究报告《首次覆盖报告:盘龙七片引领发展,一体两翼战略初现成效》,本报告对盘龙药业给出买入评级,当前股价为31.48元。公司核心产品盘龙七片稳健增长,未来有望进入基药目录后实现进一步放量。首次覆盖,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800030046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","002864"],"gpt_icon":0},{"id":"2490828727","title":"医药板块又爆了!医药商业“扛大旗”,行业将迎反转曙光?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490828727","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490828727?lang=zh_cn&edition=full","pubTime":"2024-12-12 11:42","pubTimestamp":1733974975,"startTime":"0","endTime":"0","summary":"开开实业、人民同泰领涨","market":"sg","thumbnail":"https://img3.gelonghui.com/0433a-af80b551-80b3-4ce3-8959-228f2e481322.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/0433a-af80b551-80b3-4ce3-8959-228f2e481322.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1468831","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0077","600422","BK0224","BK0209","BK1515","BK0097","BK0060","BK0250","BK1574","301017","BK0188","600829","BK0239","BK1161","300391","BK0184","600272","BK0099","603716","BK0086","002864","09939","600833","300937","603883","301408","BK0028"],"gpt_icon":0},{"id":"2490449178","title":"异动快报:盘龙药业(002864)12月12日10点12分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2490449178","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490449178?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:15","pubTimestamp":1733969724,"startTime":"0","endTime":"0","summary":"证券之星12月12日盘中消息,10点12分盘龙药业(002864)触及涨停板。目前价格31.56,上涨10.0%。其所属行业中药目前上涨。领涨股为昆药集团。该股为食品,保健品,中药概念热股,当日食品概念上涨1.59%,保健品概念上涨0.99%,中药概念上涨0.77%。12月11日的资金流向数据方面,主力资金净流出530.08万元,占总成交额11.04%,游资资金净流出53.82万元,占总成交额1.12%,散户资金净流入583.9万元,占总成交额12.17%。近5日资金流向一览见下表:盘龙药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200011031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746827223103,"stockEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0692},{"period":"3month","weight":0.0204},{"period":"6month","weight":-0.0513},{"period":"1year","weight":-0.082},{"period":"ytd","weight":-0.0941}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"26483人(较上一季度减少6.16%)","perCapita":"2793股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"10628万元","survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售及医药物流。公司主要产品包括盘龙七片、白芍总苷胶囊、痹祺胶囊、尪痹胶囊、尪痹片、盘龙七药酒、骨松宝片、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、益母草颗粒、参苓白术散、小儿麦枣咀嚼片、小儿咽扁颗粒、公司大健康产品。公司被评为“国家企业技术中心”。2020年6月6日公司的独家品种盘龙七片被评选为首届陕西“秦药”优势中成药品种,盘龙七片处方中的盘龙七药材被评为陕西“秦药”区域特色中草药,进一步提升了公司盘龙品牌。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}